*ST双成 (002693)
Hainan Shuangcheng Pharmaceuticals Co.,Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 41468.98
- Circulating A-Shares(W): 41098.16
- Earnings Per Share(RMB): -0.0061
- Net Assets Per Share(RMB): 0.9426
- Operating Revenue(W RMB): 16890.38
- Total Profit(W RMB): -753.89
- Net Profit Attributable to Parent(W RMB): -252.35
- Net Profit Growth Rate(%): 93.33
- Weighted Return on Equity(%): -0.6400
- Operating Cash Flow Per Share(RMB): 0.0770
- Undistributed Profit Per Share(RMB): -1.0316
- Capital Reserve Per Share(RMB): 0.8920
2. Main Business
The main business covers:
- Research, development, production, and sales of pharmaceutical injections
- Research, development, production, and sales of solid preparations
- Research, development, production, and sales of active pharmaceutical ingredients (APIs)
3. Company Basic Information
- Company Name: Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- Listing Date: 2012-08-08
- Industry: Pharmaceutical Manufacturing
- Address: No. 16 Xingguo Road, Xiuying District, Haikou City, Hainan Province, China
- Website: www.shuangchengmed.com
- Company Profile: The predecessor of Hainan Shuangcheng Pharmaceuticals Co., Ltd., Hainan Shuangcheng Pharmaceutical Co., Ltd., was established on May 22, 2000. On October 9, 2010, it was approved to be restructured into a joint-stock limited company. The company is mainly engaged in the research, development, production, and sales of pharmaceutical injections, solid preparations, and APIs.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Hainan Shuangcheng Investment Co., Ltd. | Corporate Entity | 13651.65 | 33.22 |
| 2 | HSP INVESTMENT HOLDINGS LIMITED | Corporate Entity | 6459.94 | 15.72 |
| 3 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 218.94 | 0.53 |
| 4 | Beijing Jinhui International Investment Co., Ltd. | Corporate Entity | 120.00 | 0.29 |
5. Concept Sectors
- ST Sector
- Hainan Free Trade Port
- Generic Drugs
- CXO Concept
- Assisted Reproduction
- Hepatitis Concept
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information